Related Experiment Video
Updated: Jun 18, 2026

The Intra-Aortic Balloon Pump
Published on: February 5, 2021
A review of cardiogenic shock in acute myocardial infarction
1Department of Medicine, Aga Khan University, Stadium Road, P.O. Box 3500, Karachi, Pakistan.
Insights
Cardiogenic shock, a major cause of death after heart attack, requires prompt diagnosis and treatment. Advanced therapies like PCI and CABG improve long-term survival, with ongoing research into new treatments.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock is the leading cause of mortality in acute myocardial infarction patients.
- It is strongly linked to ST-segment elevation myocardial infarction (STEMI) and comorbidities, presenting with hypotension and hypoperfusion.
- Timely diagnosis and supportive interventions are critical for patient outcomes.
Purpose of the Study:
- To review the current understanding and management of cardiogenic shock.
- To highlight the role of reperfusion therapies and emerging research areas.
Main Methods:
- Review of existing literature on cardiogenic shock management.
- Analysis of treatment strategies including medical therapy, mechanical support, and reperfusion.
Main Results:
- Intra-aortic balloon counterpulsation, fibrinolytic therapy, percutaneous intervention (PCI), and coronary artery bypass grafting (CABG) are key interventions.
- PCI and CABG demonstrate long-term mortality reduction.
- Research into inflammatory mediators and mechanical support devices is ongoing.
Conclusions:
- Prompt diagnosis and supportive care, followed by reperfusion strategies, are essential for managing cardiogenic shock.
- Percutaneous intervention and coronary artery bypass grafting significantly reduce long-term mortality.
- Future advancements may involve novel therapies targeting inflammation and improved mechanical support systems.
Abstract:
Cardiogenic shock continues to be the most common cause of death in patients hospitalized with acute myocardial infarction. It has also been frequently associated with ST-segment elevation myocardial infarction (STEMI) and patients with co-morbidities. Cardiogenic shock presents with low systolic blood pressure and clinical signs of hypoperfusion. Rapid diagnosis and supportive therapy in the form of medications, airway support and intra-aortic balloon counterpulsation is required. Initial stabilization can be followed by reperfusion by fibrinolytic therapy, emergent percutaneous intervention (PCI) or coronary artery bypass grafting (CABG). The latter two have been found to decrease mortality in the long term. Research is being carried out on the role of inflammatory mediators in the clinical manifestation of cardiogenic shock. Mechanical support devices also show promise in the future.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Introduction Cardiac Emergencies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cardiopulmonary Resuscitation IV: Pharmacological Management
Acute Coronary Syndrome III: Diagnostic Studies

